= Discovery stage. (17.55%, 2019 US)
= Translation stage. (42.72%, 2019 US)
= Clinically available. (39.74%, 2019 US)
MSACL 2019 US : Beppler

MSACL 2019 US Abstract

Self-Classified Topic Area(s): Data Science

No Typing Allowed: Reflections and Advice One Year After Automating All Mass Spectrometry Result Entry at a Regional Clinical Reference Laboratory

Benjamin K Beppler
TriCore Reference Laboratories, Albuquerque, NM


Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
 Benjamin Beppler (Presenter)
TriCore Reference Laboratories

Presenter Bio: Ben Beppler has worked at TriCore Reference Laboratories for 6 years, where he currently serves as a Senior Development Scientist specializing in separation sciences. His assay development responsibilities include hormone, vitamin, therapeutic drugs, and drugs of abuse assays.

Relevant Financial Disclosures (within past 24 months)
No relevant financial relationship(s) to disclose.

Abstract

As the role of mass spectrometry (MS) continues to expand in the clinical laboratory, automation becomes a necessity for high volume assays. However, automation for even low volume assays can make sense if implemented within a uniform workflow. In conjunction with a recent LIS upgrade, we chose to move from a mix of data entry processes (including significant manual entry) to a uniform, interfaced workflow across nearly all assays. All MS results are now resulted via an instrument interface, resulting in over 900 hours of tech time savings per year, equivalent to a 92% reduction in time required to release MS results. Our biggest takeaway from the project was that while building the interface for the first assay was quite time consuming, subsequent builds required an almost trivial amount of time relative to the annual time savings over manual entry, even for our lowest volume assays.